MNMD - Mind Medicine  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNMD is currently covered by 1 analysts with an average price target of $20. This is a potential upside of $16.26 (30.04%) from yesterday's end of day stock price of $15.38.

Mind Medicine 's activity chart (see below) currently has 28 price targets and 40 ratings on display. The stock rating distribution of MNMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.59% with an average time for these price targets to be met of 195.94 days.

Highest price target for MNMD is $20, Lowest price target is $20, average price target is $20.

Most recent stock forecast was given by from RBC on 07-Nov-2025.

Currently out of the existing stock ratings of MNMD, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Nov-2022

$20

$4.62 (30.04%)

$22

Buy Since 29-May-2024

$16

$0.62 (4.03%)

$27

Show more analysts

Please expand the browser size to see the chart

What is MNMD (Mind Medicine ) average time for price targets to be met?

On average it took 195.94 days on average for the stock forecasts to be realized with a an average price target met ratio 36.59

Which analyst has the current highest performing score on MNMD (Mind Medicine ) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the most public recommendations on MNMD (Mind Medicine )?

Brian Abrahams works at RBC and has 37 price targets and 24 ratings on MNMD

Which analyst is the currently most bullish on MNMD (Mind Medicine )?

Jonathan Aschoff with highest potential upside - $20.62

Which analyst is the currently most reserved on MNMD (Mind Medicine )?

Jason Mccarthy with lowest potential downside - -$7.38

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?